Active	Status	Sponsor type	Region	Phase	Filter
16 Active 1 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Martín, María José
GRACE, NCT05636709: National GMA Post-market Clinical Follow-up Study	Recruiting	N/A	350	Europe	Adacolumn	Adacyte Therapeutics SL	Crohn Disease, Ulcerative Colitis	06/26	06/26
Fernandez, María T
NCT05788497: Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids	Terminated	3	21	Europe	Hemorrane plus, Hemorrane, Placebo	Faes Farma, S.A., Dynamic Science S.L.	Haemorrhoids Without Complication	01/24	01/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Martín, María José
GRACE, NCT05636709: National GMA Post-market Clinical Follow-up Study	Recruiting	N/A	350	Europe	Adacolumn	Adacyte Therapeutics SL	Crohn Disease, Ulcerative Colitis	06/26	06/26
Fernandez, María T
NCT05788497: Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids	Terminated	3	21	Europe	Hemorrane plus, Hemorrane, Placebo	Faes Farma, S.A., Dynamic Science S.L.	Haemorrhoids Without Complication	01/24	01/24